Why shouldn't second‑generation antihistamines be used for a cold or flu? | Rounds Why shouldn't second‑generation antihistamines be used for a cold or flu? | Rounds
Loading...

Why shouldn't second‑generation antihistamines be used for a cold or flu?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Antihistamine Use for Common Cold and Influenza Symptoms

Second-generation (nonsedating) H1 antihistamines are not recommended for routine treatment of common cold symptoms because evidence shows no meaningful benefit for cold symptom control. [1][2][3] For influenza, symptom improvement still does not justify antihistamine use because available guidance prioritizes early antiviral treatment for eligible patients rather than antihistamines. [1]

Evidence of Lack of Benefit for Common Cold

Evidence is lacking to support antihistamines as monotherapy for effective relief of common cold symptoms. [2] Newer-generation nonsedating antihistamines are reported as ineffective for reducing cough associated with the common cold. [3] In the common cold setting, management is focused on supportive care rather than antihistamine therapy. [1]

Mechanistic Explanation for Clinical Inutility

Common cold symptoms are driven by viral upper-respiratory infection processes rather than histamine-mediated allergy pathways. [2] When symptoms are not primarily histamine mediated, H1 receptor blockade has limited expected clinical effect for cold and flu-like syndromes. [2]

Influenza Treatment Priorities

When illness is consistent with influenza, antiviral treatment can lessen symptoms and shorten illness duration. [1] Antihistamines are not identified as effective disease-modifying influenza therapies in guidance for respiratory virus illness management. [1]

Common Harms and Risk Tradeoffs

Symptomatic therapy requires weighing potential benefits against adverse effects. [2] Use of ineffective therapy increases exposure to adverse effects without reducing illness duration. [2]

Situations Where Antihistamines Are Appropriate

Antihistamines are appropriate for allergic rhinitis symptom control rather than routine viral cold or influenza symptom management. [1] For patients with cold-like symptoms, evaluation to distinguish COVID-19 or influenza supports selection of effective targeted treatments rather than antihistamines. [1]

Clinical Alternative Symptom Management Approaches

Supportive measures are recommended for most common cold cases because the illness typically improves on its own. [1] Nonprescription supportive interventions and appropriate OTC symptom relief options are recommended rather than routine antihistamine monotherapy for cold symptoms. [1][2] If bacterial complications are suspected, evaluation for complications is recommended because antibiotics do not treat viral illness. [1]

Related Questions